Trials / Sponsors / Vera Therapeutics, Inc.
Vera Therapeutics, Inc.
Industry · 6 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Atacicept in Multiple Glomerular Diseases pMN, IgAN, Nephrotic Syndrome | Phase 2 | 2025-07-07 |
| Active Not Recruiting | Monthly Dosing of Atacicept in IgAN IgA Nephropathy (IgAN), Berger Disease | Phase 2 | 2025-05-29 |
| Enrolling By Invitation | A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept IgA Nephropathy (IgAN), Renal and Urinary Disorders, Berger Disease | Phase 2 | 2024-12-01 |
| Active Not Recruiting | Atacicept in Subjects With IgA Nephropathy IgA Nephropathy, Berger Disease | Phase 3 | 2023-06-29 |
| Withdrawn | Atacicept in Subjects With Active Lupus Nephritis (COMPASS) Lupus Nephritis (LN) | Phase 3 | 2022-11-02 |
| Completed | A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant R BK Virus Infection | Phase 2 | 2020-08-05 |